Erratum: Recent progress in studies of infantile hemangioma (The Journal of Dermatology (2010) 37 (283-298) DOI:10.1111/j.1346-8138.2010.00813.x);Recent progress in studies of infantile hemangioma

Journal of Dermatology

Volumn 37, Issue 4, 2010, Pages 283-298

  Jinnin, Masatoshi ^a   Ishihara, Tsuyoshi ^a   Boye, Eileen ^b   Olsen, Bjorn R ^b  

^a KUMAMOTO UNIVERSITY   (Japan)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

Author keywords

Cytokine; Skin tumor; Vascular anomalies

Indexed keywords

ALPHA INTERFERON; ANGIOPOIETIN RECEPTOR; BECAPLERMIN; BLEOMYCIN; CALCITONIN GENE RELATED PEPTIDE; CD31 ANTIGEN; CD34 ANTIGEN; CORTICOSTEROID; CYCLOPHOSPHAMIDE; ENDOSIALIN; EOSIN; GLUCOSE TRANSPORTER; IMIQUIMOD; INTERFERON; PROPRANOLOL; STEROID; TRANSCRIPTION FACTOR NFAT; VASCULOTROPIN; VASCULOTROPIN RECEPTOR; VINCRISTINE;

ANGIOGRAPHY; ARTIFICIAL EMBOLISM; CEREBRAL PALSY; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CRYOSURGERY; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; EXCISION; HEMANGIOMA; HISTOLOGY; HUMAN; INFANT; INFANTILE HEMANGIOMA; MAST CELL; PATHOLOGICAL ANATOMY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PULSED DYE LASER; REVIEW; SCLEROTHERAPY; SIGNAL TRANSDUCTION; VASCULAR TUMOR;

EID: 77950278723     PISSN: 03852407     EISSN: 13468138     Source Type: Journal    
DOI: 10.1111/j.1346-8138.2011.01264.x     Document Type: Erratum

References (136)

1. Flamme I, Frolich T, Risau W. Molecular mechanisms of vasculogenesis and embryonic angiogenesis. J Cell Physiol 1997 173 : 206 210.
2. Sato Y, Kanno S, Oda N et al. Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction. Ann NY Acad Sci 2000 902 : 201 205.
3. Shibuya M. Structure and dual function of vascular endothelial growth factor receptor-1 (Flt-1). Int J Biochem Cell Biol 2001 33 : 409 420.
4. Shibuya M, Claesson-Welsh L. Signal transduction by VEGF receptors in regulation of angiogenesis and lymphangiogenesis. Exp Cell Res 2006 312 : 549 560.
5. Timur AA, Driscoll DJ, Wang Q. Biomedicine and diseases: the Klippel-Trenaunay syndrome, vascular anomalies and vascular morphogenesis. Cell Mol Life Sci 2005 62 : 1434 1447.
6. Bergers G, Song S. The role of pericytes in blood-vessel formation and maintenance. Neuro Oncol 2005 7 : 452 464.
7. Cleaver O, Melton DA. Endothelial signaling during development. Nat Med 2003 9 : 661 668.
8. Jain RK. Molecular regulation of vessel maturation. Nat Med 2003 9 : 685 693.
9. Enis DR, Shepherd BR, Wang Y et al. Induction, differentiation, and remodeling of blood vessels after transplantation of Bcl-2-transduced endothelial cells. Proc Natl Acad Sci USA 2005 102 : 425 430.
10. Saharinen P, Tammela T, Karkkainen MJ, Alitalo K. Lymphatic vasculature: development, molecular regulation and role in tumor metastasis and inflammation. Trends Immunol 2004 25 : 387 395.
11. Chiller KG, Frieden IJ, Arbiser JL. Molecular pathogenesis of vascular anomalies: classification into three categories based upon clinical and biochemical characteristics. Lymphat Res Biol 2003 1 : 267 281.
12. Mulligan-Kehoe MJ, Simons M. Vascular disease in scleroderma: angiogenesis and vascular repair. Rheum Dis Clin North Am 2008 34 : 73 79.
13. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982 69 : 412 423.
14. Boye E, Jinnin M, Olsen BR. Infantile hemangioma: challenges, new insights, and therapeutic promise. J Craniofac Surg 2009 20 : 678 684.
15. Chiller KG, Passaro D, Frieden IJ. Hemangiomas of infancy: clinical characteristics, morphologic subtypes, and their relationship to race, ethnicity, and sex. Arch Dermatol 2002 138 : 1567 1576.
16. Mulliken JB, Fishman SJ, Burrows PE. Vascular Anomalies. Mosby, St. Louis, MO 2000 : 517-584.
17. Mulliken JB, Young AE. Vascular birthmarks: hemangiomas and malformations. WB Saunders, Philadelphia 1988 : 64 72.
18. Mulliken JB. Cutaneous vascular anomalies. Semin Vasc Surg 1993 6 : 204 218.
19. North PE, Waner M, Buckmiller L, James CA, Mihm MC Jr. Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol 2006 15 : 303 317.
20. Esterly NB. Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Pediatr 1996 26 : 3 39.
21. Chang LC, Haggstrom AN, Drolet BA et al. Growth characteristics of infantile hemangiomas: implications for management. Pediatrics 2008 122 : 360 367.
22. Drolet BA, Esterly NB, Frieden IJ. Hemangiomas in children. N Engl J Med 1999 341 : 173 181.
23. Haggstrom AN, Lammer EJ, Schneider RA, Marcucio R, Frieden IJ. Patterns of infantile hemangiomas: new clues to hemangioma pathogenesis and embryonic facial development. Pediatrics 2006 117 : 698 703.
24. Waner M, North PE, Scherer KA, Frieden IJ, Waner A, Mihm MC Jr. The nonrandom distribution of facial hemangiomas. Arch Dermatol 2003 139 : 869 875.
25. Haggstrom AN, Drolet BA, Baselga E et al. Prospective study of infantile hemangiomas: clinical characteristics predicting complications and treatment. Pediatrics 2006 118 : 882 887.
26. Mulliken JB. Update on hemangioma. Pediatr Int 1999 14 : 132 134.
27. Metry DW, Haggstrom AN, Drolet BA et al. A prospective study of PHACE syndrome in infantile hemangiomas: demographic features, clinical findings, and complications. Am J Med Genet A 2006 140 : 975 986.
28. Huang SA, Tu HM, Harney JW et al. Severe hypothyroidism caused by type 3 iodothyronine deiodinase in infantile hemangiomas. N Engl J Med 2000 343 : 185 189.
29. Girard C, Ignore M, Guillot B, Bessis D. PELVIS syndrome. Arch Dermatol 2006 142 : 884 888.
30. Stockman A, Boralevi F, Taieb A, Leaute-Labreze C. SACRAL syndrome: spinal dysraphism, anogenital, cutaneous, renal, and urologic anomalies associated with an angioma of lumbosacral localization. Dermatology 2007 214 : 40 45.
31. Pandey A, Gangopadhyay AN, Upadhyay VD. Evaluation and management of infantile hemangioma: an overview. Ostomy Wound Manage 2008 54 : 22 29.
32. Jacobs AH. Strawberry hemangiomas: the natural history of the untreated lesion. Calif Med 1957 86 : 8 10.
33. Esterly NB. Cutaneous hemangiomas, vascular stains and malformations, and associated syndromes. Curr Probl Dermatol 1995 VII : 65 108.
34. Moroz B Long-Term Follow-up of Hemangiomas in Children. CV Mosby, St Louis, MO 1982 : 27-35.
35. Boscolo E, Bischoff J. Vasculogenesis in infantile hemaniogma. Angiogenesis 2009 12 : 197 207.
36. Bischoff J. Monoclonal expansion of endothelial cells in hemangioma: an intrinsic defect with extrinsic consequences? Trends Cardiovasc Med 2002 12 : 220 224.
37. Smoller BR, Apfelberg DB. Infantile (juvenile) capillary hemangioma: a tumor of heterogeneous cellular elements. J Cutan Pathol 1993 20 : 330 336.
38. Mancini AJ, Smoller BR. Proliferation and apoptosis within juvenile capillary hemangiomas. Am J Dermatopathol 1996 18 : 505 514.
39. Hemangioma Investigator Group, Haggstrom AN, Drolet BA et al. Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics. J Pediatr 2007 150 : 291 294.
40. Garzon MC, Drolet BA, Baselga E et al. Comparison of infantile hemangiomas in preterm and term infants: a prospective study. Arch Dermatol 2008 144 : 1231 1232.
41. Amir J, Metzker A, Krikler R, Reisner SH. Strawberry hemangioma in preterm infants. Pediatr Dermatol 1986 3 : 331 332.
42. Holmdahl K. Cutaneous hemangiomas in premature and mature infants. Acta Paediatr 1955 44 : 370 379.
43. Drolet BA, Swanson EA, Frieden IJ Hemangioma Investigator Group. Infantile hemangiomas: an emerging health issue linked to an increased rate of low birth weight infants. J Pediatr 2008 153 : 712 715.
44. Cheung DS, Warman ML, Mulliken JB. Hemangioma in twins. Ann Plast Surg 1997 38 : 269 274.
45. Hidano A, Purwoko R, Jitsukawa K. Statistical survey of skin changes in Japanese neonates. Pediatr Dermatol 1986 3 : 140 144.
46. Shih IH, Lin JY, Chen CH, Hong HS. A birthmark survey in 500 newborns: clinical observation in two northern Taiwan medical center nurseries. Chang Gung Med J 2007 30 : 220 225.
47. Mulliken JB, Enjolras O. Congenital hemangiomasandinfantile hemangioma: missinglinks. J Am Acad Dermatol 2004 50 : 875 882.
48. Berenguer B, Mulliken JB, Enjolras O et al. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 2003 6 : 495 510.
49. Gorincour G, Kokta V, Rypens F, Garel L, Powell J, Dubois J. Imaging characteristics of two subtypes of congenital hemangiomas: rapidly involuting congenital hemangiomas and non-involuting congenital hemangiomas. Pediatr Dermatol 2005 35 : 1178 1185.
50. Metry DW, Hebert AA. Benign cutaneous vascular tumors of infancy: when to worry, what to do. Arch Dermatol 2000 136 : 905 914.
51. Bakaris S, Karabiber H, Yuksel M, Parmaksiz G, Kiran H. Case of large placental chorioangioma associated with diffuse neonatal hemangiomatosis. Pediatr Dev Pathol 2004 7 : 258 261.
52. Sangueza OP, Requena L. Pathology of Vascular Skin Lesions: Clinicopathological Correlations. Humana Press, Totowa, 2003 : 136-150.
53. Zhang L, Lin XX, Qi ZL et al. Role of urinary basic fibroblast growth factor in differentiating hemangiomas from vascular malformation. Zhonghua Wai Ke Za Zhi 2006 44 : 186 188.
54. Zhang L, Lin X, Wang W et al. Circulating level of vascular endothelial growth factor in differentiating hemangioma from vascular malformation patients. Plast Reconstr Surg 2005 116 : 200 204.
55. Przewratil P, Sitkiewicz A, Wyka K, Andrzejewska E. Serum levels of vascular endothelial growth factor and basic fibroblastic growth factor in children with hemangiomas and vascular malformations - preliminary report. Pediatr Dermatol 2009 26 : 399 404.
56. North PE, Waner M, Mizeracki A, Mihm MC Jr. GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol 2000 31 : 11 22.
57. Leon-Villapalos J, Wolfe K, Kangesu L. GLUT-1: an extra diagnostic tool to differentiate between haemangiomas and vascular malformations. Br J Plast Surg 2005 58 : 348 352.
58. Dubois J, Patriquin HB, Garel L et al. Soft-tissue hemangiomas in infants and children: diagnosis using Doppler sonography. AJR Am J Roentgenol 1998 171 : 247 252.
59. Dubois J, Garel L, David M, Powell J. Vascular soft-tissue tumors in infancy: distinguishing features on Doppler sonography. AJR Am J Roentgenol 2002 178 : 1541 1545.
60. Meyer JS, Hoffer FA, Barnes PD, Mulliken JB. Biological classification of soft-tissue vascular anomalies: MR correlation. AJR Am J Roentgenol 1991 157 : 559 564.
61. Moukaddam H, Pollak J, Haims AH. MRI characteristics and classification of peripheral vascular malformations and tumors. Skeletal Radiol 2009 38 : 535 547.
62. Burrows PE, Mulliken JB, Fellows KE, Strand RD. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol 1983 141 : 483 488.
63. Rubin GD, Rofsky NM. CT and MR Angiography: Comprehensive Vascular Assessment. Lippincott Williams & Wilkins, Philadelphia, 2008 : 1118-1184.
64. Zvulunov A, Metzker A. Hemangiomas and vascular malformations: unapproved treatments. Clin Dermatol 2002 20 : 660 667.
65. Nguyen J, Fay A. Pharmacologic therapy for periocular infantile hemangiomas: a review of the literature. Semin Ophthalmol 2009 24 : 178 184.
66. Sloan GM, Reinisch JF, Nichter LS, Saber WL, Lew K, Morwood DT. Intralesional corticosteroid therapy for infantile hemangiomas. Plast Reconstr Surg 1989 83 : 459 467.
67. Metz BJ, Rubenstein MC, Levy ML, Metry DW. Response of ulcerated perineal hemangiomas of infancy to becaplermin gel, a recombinant human platelet-derived growth factor. Arch Dermatol 2004 140 : 867 870.
68. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon-α-2a therapy for life-threatening hemangioma of infancy. N Engl J Med 1992 326 : 1456 1463.
69. Enjolras O, Brevière GM, Roger G et al. Vincristine treatment for function- and life-threatening infantile hemangioma. Arch Pediatr 2004 11 : 99 107.
70. Garzon MC, Lucky AW, Hawrot A, Frieden IJ. Ultrapotent topical corticosteroid treatment of hemangiomas of infancy. J Am Acad Dermatol 2005 52 : 281 286.
71. McCuaig CC, Dubois J, Powell J et al. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma. Pediatr Dermatol 2009 26 : 203 212.
72. Pandey A, Gangopadhyay AN, Gopal SC et al. Twenty years' experience of steroids in infantile hemangioma-a developing country's perspective. J Pediatr Surg 2009 44 : 688 694.
73. Léauté-Labrèze C, Dumas de la Roque E, Hubiche T, Boralevi F, Thambo JB, Taïeb A. Propranolol for severe hemangiomas of infancy. N Engl J Med 2008 358 : 2649 2651.
74. Yu H, Qin A. Could local delivery of bisphosphonates be a new therapeutic choice for hemangiomas? Med Hypotheses 2009 73 : 495 497.
75. Shaw WC. Folklore surrounding facial deformity and the origins of facial prejudice. Br J Plast Surg 1981 34 : 237 246.
76. Dadras SS, North PE, Bertoncini J, Mihm MC, Detmar M. Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol 2004 17 : 1068 1079.
77. Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman J, Ezekowitz RA. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994 93 : 2357 2364.
78. North PE, Waner M, Mizeracki A. A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol 2001 137 : 559 570.
79. Ritter MR, Reinisch J, Friedlander SF, Friedlander M. Myeloid cells in infantile hemangioma. Am J Pathol 2006 168 : 621 628.
80. Kraling BM, Razon MJ, Boon LM et al. E- selectin is present in proliferating endothelial cells in human hemangiomas. Am J Pathol 1996 148 : 1181 1191.
81. Barnés CM, Huang S, Kaipainen A et al. Evidence by molecular profiling for a placental origin of infantile hemangioma. Proc Natl Acad Sci USA 2005 102 : 19097 19102.
82. Li Q, Yu Y, Bischoff J, Mulliken JB, Olsen BR. Differential expression of CD146 in tissues and endothelial cells derived from infantile haemangioma and normal human skin. J Pathol 2003 201 : 296 302.
83. Mulliken JB, Zetter BR, Folkman J. In vitro characteristics of endothelium from hemangiomas and vascular malformations. Surgery 1982 92 : 348 353.
84. Dosanjh A, Chang J, Bresnick S et al. In vitro characteristics of neonatal hemangioma endothelial cells: similarities and differences between normal neonatal and fetal endothelial cells. J Cutan Pathol 2000 27 : 441 450.
85. Boye E, Yu Y, Paranya G, Mulliken JB, Olsen BR, Bischoff J. Clonality and altered behavior of endothelial cells from hemangiomas. J Clin Invest 2001 107 : 745 752.
86. Berard M, Sordello S, Ortega N et al. Vascular endothelial growth factor confers a growth advantage in vitro and in vivo to stromal cells cultured from neonatal hemangiomas. Am J Pathol 1997 150 : 1315 1326.
87. Walter JW, North PE, Waner M et al. Somatic mutation of vascular endothelial growth factor receptors in juvenile hemangioma. Genes Chromosomes Cancer 2002 33 : 295 303.
88. Jinnin M, Medici D, Park L et al. Suppressed NFAT-dependent VEGFR1 expression and constitutive VEGFR2 signaling in infantile hemangioma. Nat Med 2008 14 : 1236 1246.
89. Yu Y, Varughese J, Brown LF, Mulliken JB, Bischoff J. Increased Tie2 expression, enhanced response to angiopoietin-1, and dysregulated angiopoietin-2 expression in hemangioma-derived endothelial cells. Am J Pathol 2001 159 : 2271 2280.
90. Picard A, Boscolo E, Khan ZA et al. IGF-2 and FLT-1/VEGF-R1 mRNA levels reveal distinctions and similarities between congenital and common infantile hemangioama. Pediatr Res 2008 63 : 263 267.
91. Ferrara N. The role of VEGF in the regulation of physiological and pathological angiogenesis. EXS 2005 94 : 209 231.
92. Roberts DM, Kearney JB, Johnson JH, Rosenberg MP, Kumar R, Bautch VL. The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation. Am J Pathol 2004 164 : 1531 1535.
93. Chang J, Most D, Bresnick S et al. Proliferative hemangiomas: analysis of cytokine gene expression and angiogenesis. Plast Reconstr Surg 1999 103 : 1 9.
94. Blei F, Walter J, Orlow SJ, Marchuk DA. Familial segregation of hemangiomas and vascular malformations as an autosomal dominant trait. Arch Dermatol 1998 134 : 718 722.
95. Walter JW, Blei F, Anderson JL, Orlow SJ, Speer MC, Marchuk DA. Genetic mapping of a novel familial form of infantile hemangioma. Am J Med Genet 1999 82 : 77 83.
96. Ritter MR, Dorrell MI, Edmonds J, Friedlander SF, Friedlander M. Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis. Proc Natl Acad Sci USA 2002 99 : 7455 7460.
97. Calicchio ML, Collins T, Kozakewich HP. Identification of signaling systems in proliferating and involuting phase infantile hemangiomas by genome-wide transcriptional profiling. Am J Pathol 2009 174 : 1638 1649.
98. Fong GH, Rossant J, Gertsenstein M, Breitman ML. Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium. Nature 1995 376 : 66 70.
99. Wakiya K, Begue A, Stehelin D, Shibuya M. A cAMP response element and an Ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (vascular endothelial growth factor receptor 1) gene. J Biol Chem 1996 271 : 30823 30828.
100. Hogan PG, Chen L, Nardone J, Rao A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev 2003 17 : 2205 2232.
101. Schwartz MA. Spreading of human endothelial cells on fibronectin or vitronectin triggers elevation of intracellular free calcium. J Cell Biol 1993 120 : 1003 1010.
102. Leavesley DI, Schwartz MA, Rosenfeld M, Cheresh DA. Integrin β1- and β3-mediated endothelial cell migration is triggered through distinct signaling mechanisms. J Cell Biol 1993 121 : 163 170.
103. Jones NP, Peak J, Brader S, Eccles SA, Katan M. PLCγ1 is essential for early events in integrin signalling required for cell motility. J Cell Sci 2005 118 : 2695 2706.
104. Aplin AE, Howe A, Alahari SK, Juliano RL. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev 1998 50 : 197 263.
105. Sjaastad MD, Nelson WJ. Integrin-mediated calcium signaling and regulation of cell adhesion by intracellular calcium. Bioessays 1997 19 : 47 55.
106. Graef IA, Chen F, Chen L, Kuo A, Crabtree GR. Signals transduced by Ca(2+)/calcineurin and NFATc3/c4 pattern the developing vasculature. Cell 2001 105 : 863 875.
107. Lei L, Liu D, Huang Y et al. Endothelial expression of β1 integrin is required for embryonic vascular patterning and postnatal vascular remodeling. Mol Cell Biol 2008 28 : 794 802.
108. St Croix B, Rago C, Velculescu V et al. Genes expressed in human tumor endothelium. Science 2000 289 : 1197 1202.
109. Carson-Walter EB, Watkins DN, Nanda A, Vogelstein B, Kinzler KW, Croix B. Cell surface tumor endothelial markers are conserved in mice and humans. Cancer Res 2001 61 : 6649 6655.
110. Hotchkiss KA, Basile CM, Spring SC, Bonuccelli G, Lisanti MP, Terman BI. TEM8 expression stimulates endothelial cell adhesion and migration by regulating cell-matrix interactions on collagen. Exp Cell Res 2005 305 : 133 144.
111. Pramanik K, Chun CZ, Garnaas MK et al. Dusp-5 and Snrk-1 coordinately function during vascular development and disease. Blood 2009 113 : 1184 1191.
112. Qian F, Zhen F, Ong C et al. Microarray analysis of zebrafish cloche mutant using amplified cDNA and identification of potential downstream target genes. Dev Dyn 2005 233 : 1163 1172.
113. Vikkula M, Boon LM, Carraway KL 3rd. et al. Vascular dysmorphogenesis caused by an activating mutation in the receptor tyrosine kinase TIE2. Cell 1996 87 : 1181 1190.
114. Brouillard P, Ghassibé M, Penington A et al. Four common glomulin mutations cause two thirds of glomuvenous malformations ("familial glomangiomas"): evidence for a founder effect. J Med Genet 2005 42 : e13.
115. McKinsey TA, Chu Z, Tedder TF, Ballard DW. Transcription factor NF-κB regulates inducible CD83 gene expression in activated T lymphocytes. Mol Immunol 2000 37 : 783 788.
116. Barry SM, Zisoulis DG, Neal JW, Clipstone NA, Kansas GS. Induction of FucT-VII by the Ras/MAP kinase cascade in Jurkat T cells. Blood 2003 102 : 1771 1778.
117. Olferiev M, Masuda E, Tanaka S, Blank MC, Pricop L. The role of activating protein 1 in the transcriptional regulation of the human FCGR2B promoter mediated by the -343 G -> C polymorphism associated with systemic lupus erythematosus. J Biol Chem 2007 282 : 1738 1746.
118. Dudziak D, Kieser A, Dirmeier U et al. Latent membrane protein 1 of Epstein-Barr virus induces CD83 by the NF-κB signaling pathway. J Virol 2003 77 : 8290 8298.
119. Phung TL, Ziv K, Dabydeen D et al. Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin. Cancer Cell 2006 10 : 159 170.
120. Shan S, Shan G, Zhang D. Treatment of hemangioma by transfection of antisense VEGF gene. J Huazhong Univ Sci Technolog Med Sci 2009 29 : 335 339.
121. Ritter MR, Moreno SK, Dorrell MI et al. Identifying potential regulators of infantile hemangioma progression through large-scale expression analysis: a possible role for the immune system and indoleamine 2,3 dioxygenase (IDO) during involution. Lymphat Res Biol 2003 1 : 291 299.
122. Burton BK, Schulz CJ, Angle B, Burd LI. An increased incidence of hemangiomas in infants born following chorionic villus sampling (CVS). Prenat Diagn 1995 15 : 209 214.
123. Pittman KM, Losken HW, Kleinman ME et al. No evidence for maternal-fetal microchimerism in infantile hemangioma: a molecular genetic investigation. J Invest Dermatol 2006 126 : 2533 2538.
124. Régnier S, Dupin N, Le Danff C, Wassef M, Enjolras O, Aractingi S. Endothelial cells in infantile haemangiomas originate from the child and not from the mother (a fluorescence in situ hybridization-based study). Br J Dermatol 2007 157 : 158 160.
125. Pack GT, Miller TR. Hemangiomas; classification, diagnosis and treatment. Angiology 1950 1 : 405 426.
126. Khan ZA, Melero-Martin JM, Wu X et al. Endothelial progenitor cells from infantile hemangioma and umbilical cord blood display unique cellular responses to vendostatin. Blood 2006 108 : 915 921.
127. Kleinman ME, Tepper OM, Capla JM et al. Increased circulating AC133+ CD34+ endothelial progenitor cells in children with hemangioma. Lymphat Res Biol 2003 1 : 301 307.
128. Yu Y, Fuhr J, Boye E et al. Mesenchymal stem cells and adipogenesis in hemangioma involution. Stem Cells 2006 24 : 1605 1612.
129. Khan ZA, Boscolo E, Picard A et al. Multipotential stem cells recapitulate human infantile hemangioma in immunodeficient mice. J Clin Invest 2008 118 : 2592 2599.
130. Melero-Martin JM, De Obaldia ME, Kang SY et al. Engineering robust and functional vascular networks in vivo with human adult and cord blood-derived progenitor cells. Circ Res 2008 103 : 194 202.
131. Tan ST, Wallis RA, He Y, Davis PF. Mast cells and hemangioma. Plast Reconstr Surg 2004 113 : 999 1011.
132. Pasyk KA, Cherry GW, Grabb WC, Sasaki GH. Quantitative evaluation of mast cells in cellularly dynamic and adynamic vascular malformations. Plast Reconstr Surg 1984 73 : 69 77.
133. Nguyen VA, Fürhapter C, Romani N, Weber F, Sepp N. Infantile hemangioma is a proliferation of beta 4-negative endothelial cells adjacent to HLA-DR-positive cells with dendritic cell morphology. Hum Pathol 2004 35 : 739 744.
134. Isik FF, Rand RP, Gruss JS, Benjamin D, Alpers CE. Monocyte chemoattractant protein-1 mRNA expression in hemangiomas and vascular malformations. J Surg Res 1996 61 : 71 76.
135. Jang YC, Isik FF, Gibran NS. Nerve distribution in hemangiomas depends on the proliferative state of the microvasculature. J Surg Res 2000 93 : 144 148.
136. Perry BN, Govindarajan B, Bhandarkar SS et al. Pharmacologic blockade of angiopoietin-2 is efficacious against model hemangiomas in mice. J Invest Dermatol 2006 126 : 2316 2322.